Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;2(4):264-74.
doi: 10.1556/EuJMI.2.2012.4.4. Epub 2012 Dec 11.

TBNET - Collaborative research on tuberculosis in Europe

TBNET - Collaborative research on tuberculosis in Europe

C Giehl et al. Eur J Microbiol Immunol (Bp). 2012 Dec.

Abstract

Networking is a key feature of scientific success. The Tuberculosis Network European Trialsgroup (TBNET) was founded in 2006 as a non-profit, non-governmental peer-initiated scientific organization to collaboratively address research priorities in the area of tuberculosis in Europe. Today, TBNET is the largest tuberculosis research organization in Europe with nearly 500 members from 22 EU countries and 49 countries worldwide (www.tb-net.org). Apart from small multicenter basic research studies, a particular strength of TBNET is the performance of large collaborative projects, pan-European multicenter studies and database projects. In recent years, research from TBNET has substantially contributed to the understanding of the management, risk and prognosis of patients with multidrug (MDR) and extensively drug-resistant (XDR) tuberculosis and led to a better understanding of the clinical value of novel tests for the identification of adults and children with tuberculosis and latent infection with Mycobacterium tuberculosis. In 2009, two branches of TBNET were founded to specifically address tuberculosis in the pediatric population (ptbnet) and non-tuberculous mycobacterial diseases (NTM-NET). In addition to the research activities, TBNET is developing expert consensus documents for clinical management and provides training and capacity building especially for members from Eastern European countries, where tuberculosis is still a prevalent health problem.

Keywords: Mycobacterium tuberculosis, TBNET, NTM-NET, ptbnet, tuberculosis, Tuberculosis Network European Trialsgroup.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Tuberculosis is a leading cause of morbidity and mortality worldwide and is still an important healthcare problem in many parts of Europe
Fig. 2.
Fig. 2.
TBNET governance and organizational structure. The steering committee is democratically elected and closely collaborates with principal investigators and members of the network to develop projects, training and teaching activities, and fundraising
Fig. 3.
Fig. 3.
Main areas of TBNET activities
Fig. 4.
Fig. 4.
Sites of hospitals for the care of patients with MDR/XDR tuberculosis in Europe that participate in the TB PAN-NET database research project
Fig. 5.
Fig. 5.
TBNET academy. A young scientist is presenting an overview of tuberculosis immunology to other fellow participants
Fig. 6.
Fig. 6.
Attendants of the TBNET meeting in Amsterdam 2011

References

    1. WHO . Global Tuberculosis Control report. WHO; Geneva, Switzerland: 2011.
    1. Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, Thijsen S, Cirillo D, Ferrarese M, Greinert U, Fabbri LM, Richeldi L, Lange C, European Tuberculosis Network TBNET Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. The European respiratory journal. 2007 Dec 1;30(6) doi: 10.1183/09031936.00067307. - DOI - PubMed
    1. Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC, SMIRA/TBNET Study Group Clinical and operational value of the extensively drug-resistant tuberculosis definition. The European respiratory journal. 2007 Oct 1;30(4) doi: 10.1183/09031936.00077307. - DOI - PubMed
    1. Migliori GB, Ortmann J, Girardi E, Besozzi G, Lange C, Cirillo DM, Ferrarese M, De Iaco G, Gori A, Raviglione MC, SMIRA/TBNET Study Group Extensively drug-resistant tuberculosis, Italy and Germany. Emerging infectious diseases. 2007 May 1;13(5) doi: 10.3201/eid1305.070200. - DOI - PMC - PubMed
    1. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, Ravn P, TBNET Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. The European respiratory journal. 2008 Dec 1;32(6) doi: 10.1183/09031936.00055508. - DOI - PubMed

LinkOut - more resources